Author correction to “Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers” [Acta Pharmaceutica Sinica B 11 (2021) 355–372]

doi: 10.1016/j.apsb.2022.02.028

• Tingting Jiang^a, 
• Guan Wang^a, 
• Yao Liu^a, 
• Lu Feng^a, 
• Meng Wang^a, 
• Jie Liu^a, 
• Yi Chen^b, , , 
• Liang Ouyang^a, , 

• a. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu 610041, China;

• b. State Key Laboratory of Biotherapy and Cancer Center and Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China

通讯作者:

Yi Chen,E-mail:toddychan@163.com

Liang Ouyang,E-mail:ouyangliang@scu.edu.cn

• 中图分类号: https://www.sciencedirect.com/science/article/pii/S2211383522000843/pdf?md5=645f588722dd61d129d1ca06424ad169&pid=1-s2.0-S2211383522000843-main.pdf

• 计量

  • 文章访问数:  162
  • HTML全文浏览量:  110
  • PDF下载量:  0
  • 被引次数: 0

  出版历程

  • 网络出版日期:  2023-03-17